
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:36233</ns1:identifier>
    <ns1:title language="en">Three methods of isolating EVs from pleural effusion samples of patients with advanced lung adenocarcinoma-potential applications in clinical practice?</ns1:title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT
Introduction: Pleural effusion (PE) occurs in 17-23% of lung cancer (LCa) patients and it contains extracellular vesicles (EVs) from cancer cells, representing “liquid biopsy” of LCa. Isolated PE-EVs could be used for LCa diagnosis or monitoring its progression/therapy. However, there is still no standard method for isolation of EVs from pleural fluid. The aim of this work is to compare PE-EVs isolation methods that could be employed both in research  or clinical settings.  Methods: PE samples diluted in PBS (1:1) from patients with advanced non-small cell lung cancer (NSCLC) were utilized. Three methods for isolating EVs were employed: an in-house spherical porous methacrylate-based copolymer coupled with VHH antibodies (chromatography method-CH), ultracentrifugation (UC), and the Norgen Plasma/Serum Exosome Purification and RNA Isolation Mini Kit (Commercial kit-CK). For each EVs isolation method, efficiency was monitored in terms of the amount of starting sample, time required for vesicle isolation, yield, quality of the obtained isolates and overall cost. Results: In terms of the amount of starting sample, the CH and CK have an advantage, allowing work with as little as 500μL, whereas UC required several milliliters of sample (in our case, due to the rotor type, 12mL minimum). </ns1:description>
    <ns1:keyword language="en">Pleural effusion, extracellular vesicles, </ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552100</ns2:resource>
      <ns2:identifier>978-86-905626-1-9</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552102</ns2:resource>
      <ns2:identifier>https://srbevs.rs/2nd-move-symposium/</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2025-06-05T06:07:17.553Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Miodrag</ns3:firstname>
        <ns3:lastname>Vuković</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
      </ns1:entity>
      <ns1:entity seq="10">
        <ns3:firstname>Lidija</ns3:firstname>
        <ns3:lastname>Filipović</ns3:lastname>
        <ns3:institution>Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="9">
        <ns3:firstname>Nina</ns3:firstname>
        <ns3:lastname>Petrović</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="8">
        <ns3:firstname>Andrej</ns3:firstname>
        <ns3:lastname>Zečević</ns3:lastname>
        <ns3:institution>Clinic for Pulmonology, University Clinical Center of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="7">
        <ns3:firstname>Maja</ns3:firstname>
        <ns3:lastname>Kosanović</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-1143-1805</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Miljana</ns3:firstname>
        <ns3:lastname>Tanić</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Radmila</ns3:firstname>
        <ns3:lastname>Janković</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Tatjana</ns3:firstname>
        <ns3:lastname>Stanojković</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Milica</ns3:firstname>
        <ns3:lastname>Popović</ns3:lastname>
        <ns3:institution>Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Aleksandra</ns3:firstname>
        <ns3:lastname>Korać</ns3:lastname>
        <ns3:institution>Faculty of Biology, University of Belgrade, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Milena</ns3:firstname>
        <ns3:lastname>Čavić</ns3:lastname>
        <ns3:institution>Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>1608647</ns1:size>
    <ns1:location>https://phaidrabg.bg.ac.rs/o:36233</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>1</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000004</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>11A19</ns8:faculty>
      <ns8:department>11A1903</ns8:department>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A28</ns8:faculty>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A29</ns8:faculty>
      <ns8:department>11A2904</ns8:department>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A02</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">2nd MOVE Symposium Abstract book, 8-11 October 2024, Belgrade, Serbia</ns12:name_magazine>
    <ns12:publisher>Serbian Society for Extracellular Vesicles, SrbEVs with Austrian Society for Extracellular Vesicles, ASEV Baltic Society for Extracellular Vesicles, BSEV Italian Society for Extracellular Vesicles, EVIta French Society for Extracellular Vesicles, FSEV Spanish Society for Extracellular Vesicles, GEIVEX German Society for Extracellular Vesicles, GSEV United Kingdom Society for Extracellular Vesicles, UKEV</ns12:publisher>
    <ns12:releaseyear>2024</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
